Document:

EXHIBIT 10.1

 

THIRTEENTH
AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT

This THIRTEENTH
AMENDMENT TO AMENDED AND RESTATED CREDIT AGREEMENT (this “Amendment”) is made and entered into as of April
30, 2017 (the “Amendment Closing Date”) by and among Bacterin
International, Inc., a Nevada corporation (the “Borrower”), ROS
acquisition offshore lp, a Cayman Islands Exempted Limited Partnership (“ROS”), ORBIMED ROYALTY
OPPORTUNITIES II, LP, a Delaware limited partnership (“Royalty Opportunities”), and, in their capacity as
Guarantors under the Credit Agreement (as defined below), XTANT MEDICAL HOLDINGS, INC., a Delaware corporation (“Holdings”),
X-SPINE SYSTEMS, INC., an Ohio corporation (“X-Spine”) and XTANT MEDICAL, INC., a Delaware corporation
(“Xtant” and, along with Holdings and X-Spine, collectively, the “Guarantors”).

WHEREAS, the
Borrower, ROS and Royalty Opportunities are party to that certain Amended and Restated Credit Agreement, dated as of July 27, 2015,
as amended by that certain First Amendment to Amended and Restated Credit Agreement, dated as of March 31, 2016, that certain Second
Amendment to Amended and Restated Credit Agreement, dated as of May 25, 2016, that certain Third Amendment to Amended and Restated
Credit Agreement, dated as of June 30, 2016, that certain Fourth Amendment to Amended and Restated Credit Agreement, dated as of
July 29, 2016, that certain Fifth Amendment to the Amended and Restated Credit Agreement, dated as of August 12, 2016, that certain
Sixth Amendment to the Amended and Restated Credit Agreement, dated as of September 27, 2016, that certain Seventh Amendment to
the Amended and Restated Credit Agreement, dated as of December 31, 2016, that certain Eighth Amendment to Amended and Restated
Credit Agreement, dated as of January 13, 2017, that certain Ninth Amendment to Amended and Restated Credit Agreement, dated as
of January 31, 2017, that certain Tenth Amendment to Amended and Restated Credit Agreement, dated as of February 14, 2017, that
certain Eleventh Amendment to Amended and Restated Credit Agreement, dated as of February 28, 2017 and that certain Twelfth Amendment
and Waiver to Amended and Restated Credit Agreement, dated as of March 31, 2017 (the “Credit Agreement”), pursuant
to which (i) ROS and Royalty Opportunities, as Lenders under the Credit Agreement, have extended credit to the Borrower on the
terms set forth therein and (ii) each Lender has appointed ROS as the administrative agent (the “Administrative Agent”)
for the Lenders;

WHEREAS, the
Guarantors and the Administrative Agent entered into an Amended and Restated Guarantee, dated as of July 31, 2015 and supplemented
on September 11, 2015, pursuant to which the Guarantors have agreed to guarantee the Obligations of the Borrower under the Credit
Agreement;

WHEREAS, pursuant
to Section 11.1 of the Credit Agreement, the Credit Agreement may be amended by an instrument in writing signed by each of the
Borrower and the Administrative Agent (acting on behalf of the Lenders);

WHEREAS, the
Borrower and the Lenders desire to amend certain provisions of the Credit Agreement as provided in this Amendment.

    	 	  	 

     

    

NOW, THEREFORE,
in consideration of the mutual agreements herein contained, and for other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the parties hereto agree as follows:

1.               
Definitions; Loan Document. Capitalized terms used herein without definition
shall have the meanings assigned to such terms in the Credit Agreement. This Amendment shall constitute a Loan Document for all
purposes of the Credit Agreement and the other Loan Documents.

2.               
Amendments to Section 3.6. Section 3.6 of the Credit Agreement is hereby amended
by deleting the last sentence from such Section 3.6 in its entirety and inserting the following as the last sentence thereof:

“Notwithstanding the foregoing,
interest accrued on the Loans for the Fiscal Quarters ended on December 31, 2016 and March 31, 2017 and otherwise required to be
paid in cash on January 2, 2017 and March 31, 2017, respectively, shall instead be required to be paid in cash on May 31, 2017,
plus interest accrued on such interest from January 2, 2017 and March 31, 2017, as applicable, to the date of payment thereof at
a rate equal to the Applicable Margin plus the higher of (i) the LIBO Rate for the Fiscal Quarter ended on December 31, 2016 or
the Fiscal Quarter ended on March 31, 2017, as applicable, and (ii) 1.00%.”

3.               
Conditions to Effectiveness of Amendment. This Amendment shall become effective
upon receipt by the Borrower, the Administrative Agent, the Lenders and the Guarantors of a counterpart signature of the others
to this Amendment duly executed and delivered by each of the Borrower, the Lenders, the Administrative Agent and the Guarantors.

4.               
Expenses. The Borrower agrees to pay on demand all expenses of the Administrative
Agent (including, without limitation, the fees and out-of-pocket expenses of Covington & Burling LLP, counsel to the Administrative
Agent) incurred in connection with the Administrative Agent’s review, consideration and evaluation of this Amendment, including
the rights and remedies available to it in connection therewith, and the negotiation, preparation, execution and delivery of this
Amendment.

5.               
Representations and Warranties. The Borrower and the Guarantors represent and
warrant to each Lender as follows:

(a)             
After giving effect to this Amendment, the representations and warranties of the Borrower
and the Guarantors contained in the Credit Agreement or any other Loan Document shall, (i) with respect to representations and
warranties that contain a materiality qualification, be true and correct in all respects on and as of the date hereof, and (ii)
with respect to representations and warranties that do not contain a materiality qualification, be true and correct in all material
respects on and as of the date hereof, and except that the representations and warranties limited by their terms to a specific
date shall be true and correct as of such date.

(b)             
After giving effect to this Amendment, no Default or Event of Default under the Credit Agreement
will occur or be continuing.

    	 	 -2-	 

     

    

6.               
No Implied Amendment or Waiver. Except as expressly set forth in this Amendment,
this Amendment shall not, by implication or otherwise, limit, impair, constitute a waiver of or otherwise affect any rights or
remedies of the Administrative Agent or the Lenders under the Credit Agreement or the other Loan Documents, or alter, modify, amend
or in any way affect any of the terms, obligations or covenants contained in the Credit Agreement or the other Loan Documents,
all of which shall continue in full force and effect. Nothing in this Amendment shall be construed to imply any willingness on
the part of the Administrative Agent or the Lenders to agree to or grant any similar or future amendment, consent or waiver of
any of the terms and conditions of the Credit Agreement or the other Loan Documents.

7.               
Waiver and Release. TO INDUCE THE ADMINISTRATIVE AGENT, ACTING ON BEHALF OF
THE LENDERS, TO AGREE TO THE TERMS OF THIS AMENDMENT, THE BORROWER, THE GUARANTORS AND THEIR AFFILIATES (COLLECTIVELY, THE RELEASING
PARTIES”) REPRESENT AND WARRANT THAT AS OF THE DATE HEREOF THERE ARE NO CLAIMS OR OFFSETS AGAINST OR RIGHTS OF RECOUPMENT
WITH RESPECT TO OR DEFENSES OR COUNTERCLAIMS TO THEIR OBLIGATIONS UNDER THE LOAN DOCUMENTS AND IN ACCORDANCE THEREWITH THEY:

(a)             
WAIVE ANY AND ALL SUCH CLAIMS, OFFSETS, RIGHTS OF RECOUPMENT, DEFENSES OR COUNTERCLAIMS, WHETHER
KNOWN OR UNKNOWN, ARISING PRIOR TO THE DATE HEREOF; AND

(b)             
FOREVER RELEASE, RELIEVE, AND DISCHARGE THE ADMINISTRATIVE AGENT, THE LENDERS, THEIR OFFICERS,
DIRECTORS, SHAREHOLDERS, MEMBERS, PREDECESSORS, SUCCESSORS, ASSIGNS, ATTORNEYS, ACCOUNTANTS, AGENTS, EMPLOYEES, AND REPRESENTATIVES
(COLLECTIVELY, THE "RELEASED PARTIES"), AND EACH OF THEM, FROM ANY AND ALL CLAIMS, LIABILITIES, DEMANDS, CAUSES
OF ACTION, DEBTS, OBLIGATIONS, PROMISES, ACTS, AGREEMENTS, AND DAMAGES, OF WHATEVER KIND OR NATURE, WHETHER KNOWN OR UNKNOWN, SUSPECTED
OR UNSUSPECTED, CONTINGENT OR FIXED, LIQUIDATED OR UNLIQUIDATED, MATURED OR UNMATURED, WHETHER AT LAW OR IN EQUITY, WHICH THE RELEASING
PARTIES EVER HAD, NOW HAVE, OR MAY, SHALL, OR CAN HEREAFTER HAVE, DIRECTLY OR INDIRECTLY ARISING OUT OF OR IN ANY WAY BASED UPON,
CONNECTED WITH, OR RELATED TO MATTERS, THINGS, ACTS, CONDUCT, AND/OR OMISSIONS AT ANY TIME FROM THE BEGINNING OF THE WORLD THROUGH
AND INCLUDING THE DATE HEREOF, INCLUDING WITHOUT LIMITATION ANY AND ALL CLAIMS AGAINST THE RELEASED PARTIES ARISING UNDER OR RELATED
TO THE LOAN DOCUMENTS OR THE TRANSACTIONS CONTEMPLATED THEREBY.

(c)             
IN CONNECTION WITH THE RELEASE CONTAINED HEREIN, THE RELEASING PARTIES ACKNOWLEDGE THAT THEY
ARE AWARE THAT THEY MAY HEREAFTER DISCOVER CLAIMS PRESENTLY UNKNOWN OR UNSUSPECTED, OR FACTS IN ADDITION TO OR DIFFERENT FROM THOSE
WHICH THEY KNOW OR BELIEVE TO BE TRUE, WITH RESPECT TO THE MATTERS RELEASED HEREIN. NEVERTHELESS, IT IS THE INTENTION OF THE RELEASING
PARTIES, THROUGH THIS AGREEMENT AND WITH ADVICE OF COUNSEL, FULLY, FINALLY, AND FOREVER TO RELEASE ALL SUCH MATTERS, AND ALL CLAIMS
RELATED THERETO, WHICH DO NOW EXIST, OR HERETOFORE HAVE EXISTED. IN FURTHERANCE OF SUCH INTENTION, THE RELEASES HEREIN GIVEN SHALL
BE AND REMAIN IN EFFECT AS A FULL AND COMPLETE RELEASE OR WITHDRAWAL OF SUCH MATTERS NOTWITHSTANDING THE DISCOVERY OR EXISTENCE
OF ANY SUCH ADDITIONAL OR DIFFERENT CLAIMS OR FACTS RELATED THERETO.

    	 	 -3-	 

     

    

(d)             
THE RELEASING PARTIES COVENANT AND AGREE NOT TO BRING ANY CLAIM, ACTION, SUIT, OR PROCEEDING
AGAINST THE RELEASED PARTIES, DIRECTLY OR INDIRECTLY, REGARDING OR RELATED IN ANY MANNER TO THE MATTERS RELEASED HEREBY, AND FURTHER
COVENANT AND AGREE THAT THIS AGREEMENT IS A BAR TO ANY SUCH CLAIM, ACTION, SUIT, OR PROCEEDING.

(e)             
THE RELEASING PARTIES REPRESENT AND WARRANT TO THE RELEASED PARTIES THAT THEY HAVE NOT HERETOFORE
ASSIGNED OR TRANSFERRED, OR PURPORTED TO ASSIGN OR TRANSFER, TO ANY PERSON OR ENTITY ANY CLAIMS OR OTHER MATTERS HEREIN RELEASED.

8.               
Counterparts; Governing Law. This Amendment may be executed in any number of
counterparts and by different parties hereto on separate counterparts, each of such when so executed and delivered shall be an
original, but all of such counterparts shall together constitute but one and the same agreement. Delivery of an executed counterpart
of a signature page of this Amendment by fax transmission or other electronic mail transmission (e.g., “pdf” or “tif”)
shall be effective as delivery of a manually executed counterpart of this Amendment. THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED
IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF NEW YORK (INCLUDING FOR SUCH PURPOSE SECTIONS 5-1401 AND 5-1402 OF THE GENERAL
OBLIGATIONS LAW OF THE STATE OF NEW YORK).

[Remainder
of Page Intentionally Left Blank]

    	 	 -4-	 

     

    

IN WITNESS WHEREOF, the parties
hereto have caused this Amendment to be executed by their respective officers thereunto duly authorized as of the day and year
first above written.

	 	BACTERIN INTERNATIONAL, INC.,
	 	as the Borrower
	 	 	 	 
	 	By:  	/s/ John Gandolfo	 
	 	Name:  	John Gandolfo	 
	 	Title:    	CFO	 
	 	 	 	 
	 	 	 	 
	 	XTANT MEDICAL HOLDINGS, INC.,
	 	(fka: Bacterin International Holdings, Inc.)
	 	as a Guarantor
	 	 	 	 
	 	By:  	 /s/ John Gandolfo	 
	 	Name:  	John Gandolfo	 
	 	Title:    	CFO	 
	 	 	 	 
	 	 	 	 
	 	X-SPINE SYSTEMS, INC.,
	 	as a Guarantor
	 	 	 	 
	 	By:   	/s/ John Gandolfo	 
	 	Name:  	John Gandolfo	 
	 	Title:    	CFO	 
	 	 	 	 
	 	 	 	 
	 	XTANT MEDICAL, INC.,
	 	as a Guarantor
	 	 	 	 
	 	By:  	 /s/ John Gandolfo	 
	 	Name:  	John Gandolfo	 
	 	Title:    	CFO	 

 

Signature Page to Thirteenth Amendment to A&R Credit Agreement

 

    	 	  	 

     

    

 

	 	ROS Acquisition Offshore LP,
	 	as a Lender and as the Administrative Agent
	 	 
	 	By OrbiMed Advisors LLC, solely in its
	 	capacity as Investment Manager
	 	 	 	 
	 	 	 	 
	 	By:   	 /s/ Samuel D. Islay	 
	 	Name:  	Samuel D. Islay	 
	 	Title:    	Managing Member	 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	ORBIMED ROYALTY OPPORTUNITIES II, LP,
	 	as a Lender 
	 	 	 	 
	 	By OrbiMed ROF II LLC,
	 	its General Partner
	 	By OrbiMed Advisors LLC,
	 	its Managing Member
	 	 	 	 
	 	 	 	 
	 	By:  	  /s/ Samuel D. Islay	 
	 	Name: 	 Samuel D. Islay	 
	 	Title:   	 Managing Member	 

 

Signature Page to
Thirteenth Amendment to A&R Credit AgreementEXHIBIT 10.2

 

FORBEARANCE AGREEMENT

This Forbearance Agreement (this “Forbearance Agreement”) is entered into as of April 30,
2017, by and between (a) SILICON VALLEY BANK, a California corporation (“Bank”), and (b) (i) XTANT
MEDICAL HOLDINGS, INC., a Delaware corporation (“Holdings”), (ii) BACTERIN INTERNATIONAL, INC., a
Nevada corporation (“Bacterin”), (iii) X-SPINE SYSTEMS, INC., an Ohio corporation (“X-spine”),
and (iv) XTANT MEDICAL, INC., a Delaware corporation (“Xtant”, and together with Holdings, Bacterin and
X-spine, individually and collectively, jointly and severally, the “Borrower”).

1.               
DESCRIPTION OF EXISTING INDEBTEDNESS AND OBLIGATIONS. Among other indebtedness and obligations which may be owing
by Borrower to Bank, Borrower is indebted to Bank pursuant to a loan arrangement dated as of May 25, 2016, evidenced by, among
other documents, a certain Loan and Security Agreement, dated as of May 25, 2016, between Borrower and Bank, as amended by a certain
First Loan Modification Agreement, dated as of August 12, 2016 (as amended, the “Loan Agreement”). Capitalized
terms used but not otherwise defined herein shall have the same meaning as in the Loan Agreement.

2.               
DESCRIPTION OF COLLATERAL. Repayment of the Obligations is secured by (a) the Collateral as described in the Loan
Agreement, and (b) the “Intellectual Property Collateral”, as such term is defined in that certain Intellectual Property
Security Agreement, executed and delivered by Borrower to Bank, dated as of May 25, 2016 (the “IP Agreement”).
Hereinafter, the Loan Agreement and the IP Agreement, together with all other documents executed in connection therewith evidencing,
securing or otherwise relating to the Obligations, shall be referred to as the “Existing Loan Documents”.

3.               
ACKNOWLEDGMENT OF DEFAULTS. Borrower acknowledges that (i) an Event of Default under Section 8.2(a) of the Loan Agreement
has occurred by virtue of Borrower failing to deliver an “unqualified” opinion from an independent certified public
accounting firm, on the annual financial statements of Borrower for the fiscal year ended December 31, 2016 (such opinion includes
a “going concern” qualification), and (ii) an Event of Default or Events of Default under Section 8.3, 8.6 and/or Section
8.9 of the Loan Agreement have occurred by virtue of Borrower’s events of default under the OrbiMed Loan Documents, that
certain Indenture, dated as of July 31, 2015, by and between Holdings and Wilmington Trust, National Association, as trustee, and
certain Convertible Promissory Notes issued by Holdings to ROS Acquisition Offshore LP on April 14, 2016 (in the aggregate principal
amount of $1,428,552.78) and January 17, 2017 (in the aggregate principal amounts of $995,700 and $42,856.59), and to OrbiMed Royalty
Opportunities II, LP on April 14, 2016 (in the aggregate principal amount of $809,613.67) and January 17, 2017 (in the aggregate
principal amounts of $564,300 and $24,288.41), as a result of such “going concern” qualification (the foregoing Events
of Default described in clause (i) and clause (ii) are collectively referred to as the “Stated Defaults”).

4.               
FORBEARANCE BY BANK.

		A.	In consideration of, among other things, Borrower’s compliance with each and every term of
this Forbearance Agreement, Bank hereby agrees to forbear from exercising its rights and remedies as a result of the Stated Defaults
until the earlier of (i) a Default or an Event of Default occurs under the Loan Agreement (with the sole exception of the Stated
Defaults), (ii) the failure of Borrower to promptly, punctually, or faithfully perform or comply with any term or condition of
this Forbearance Agreement as and when required, it being expressly acknowledged and agreed that TIME IS OF THE ESSENCE, or (iii)
3:00 p.m. Pacific time on May 5, 2017 (the period commencing as of the date of the effectiveness of this Forbearance Agreement
and ending on the earlier of (i), (ii) or (iii) above shall be referred to as the “Forbearance Period”).

    	 	  	 

     

    
		B.	Borrower hereby acknowledges and agrees that nothing contained in this section or in any other
section of this Forbearance Agreement shall be deemed or otherwise construed as a waiver by Bank of the Stated Defaults or any
other Default or Event of Default (whether now existing or hereafter arising) or of any of its rights and remedies pursuant to
the Existing Loan Documents, applicable law or otherwise. This Forbearance Agreement shall only constitute an agreement by Bank
to forbear from enforcing its rights and remedies based upon the Stated Defaults, upon the terms and conditions set forth herein.
Upon the expiration of the Forbearance Period, the agreement of Bank to forbear as set forth in this Forbearance Agreement shall
automatically terminate and Bank may immediately commence enforcing its rights and remedies pursuant to the Existing Loan Documents,
applicable law or otherwise, in such order and manner as Bank may determine appropriate.

5.               
TERMS OF FORBEARANCE.

		A.	From and after the execution of this Forbearance Agreement, Borrower agrees that Bank shall have
no further obligation to make any Advances to Borrower, or to issue any other Credit Extensions for Borrower’s account, or
to provide any other extensions of credit of any kind (if an obligation exists in a particular instance) to Borrower. Notwithstanding
the foregoing, during the Forbearance Period and at the request of Borrower, Bank may, in its sole and absolute discretion, continue
to make Advances (hereinafter, such financial accommodations shall be referred to collectively as “Discretionary Financial
Accommodations” and singly as a “Discretionary Financial Accommodation”), subject, in all events,
to the terms and conditions of this Forbearance Agreement, the Loan Agreement, (including but not limited to, all limitations imposed
by the Availability Amount) and the other Loan Documents, as affected hereby. Borrower covenants and agrees that if, in the sole
and absolute discretion of Bank, Bank shall make any Discretionary Financial Accommodation during the Forbearance Period, such
act shall not constitute (i) a waiver of the Stated Defaults, or of any other Default or Event of Default which may now exist or
which may occur after the date of this Forbearance Agreement under any of the Loan Documents, or (ii) an agreement on the part
of Bank to make any further extensions of credit of any kind to Borrower at a later date.

    	 	 2	 

     

    
		B.	At all times during the Forbearance Period, Borrower shall comply with all terms and conditions
of the Loan Agreement and the other Loan Documents including, without limitation, all representations, warranties, affirmative
and negative covenants contained in the Loan Agreement and the other Loan Documents.

		C.	During the Forbearance Period, Borrower shall continue to remit all regularly scheduled payments
(whether due on account of any Credit Extension or otherwise, including all principal, interest, fees, costs and other amounts)
which may become due under the Loan Agreement, as and when such payments are due.

6.               
FEES. Borrower shall reimburse Bank for all legal fees and expenses incurred in connection with the Existing Loan
Documents and this Forbearance Agreement.

7.               
RATIFICATION OF LOAN DOCUMENTS. Borrower hereby ratifies, confirms, and reaffirms all terms and conditions of the
Loan Documents and all security or other collateral granted to the Bank, and confirms that the indebtedness secured thereby includes,
without limitation, the Obligations.

8.               
CONSISTENT CHANGES. The Existing Loan Documents are hereby amended wherever necessary to reflect the changes described
above.

9.               
RATIFICATION OF LOAN DOCUMENTS. Borrower hereby ratifies, confirms, and reaffirms all terms and conditions of the
Loan Documents and all security or other collateral granted to the Bank, and confirms that the indebtedness secured thereby includes,
without limitation, the Obligations.

10.            
NO DEFENSES OF BORROWER. Borrower hereby acknowledges and agrees that Borrower has no offsets, defenses, claims,
or counterclaims against Bank with respect to the Obligations, or otherwise, and that if Borrower now has, or ever did have, any
offsets, defenses, claims, or counterclaims against Bank, whether known or unknown, at law or in equity, all of them are hereby
expressly WAIVED and Borrower hereby RELEASES Bank from any liability thereunder.

11.            
CONTINUING VALIDITY. Borrower understands and agrees that in modifying the existing Obligations, Bank is relying
upon Borrower’s representations, warranties, and agreements, as set forth in the Existing Loan Documents. Except as expressly
modified pursuant to this Forbearance Agreement, the terms of the Existing Loan Documents remain unchanged and in full force and
effect. Bank’s agreement to forbear from enforcing it rights and remedies pursuant to this Forbearance Agreement in no way
shall obligate Bank to make any future forbearances or make any other modifications to the Obligations. Nothing in this Forbearance
Agreement shall constitute a satisfaction of the Obligations. It is the intention of Bank and Borrower to retain as liable parties
all makers of Existing Loan Documents, unless the party is expressly released by Bank in writing. No maker will be released by
virtue of this Forbearance Agreement.

12.            
JURISDICTION/VENUE/TRIAL WAIVER. Section 11 of the Loan Agreement is hereby incorporated by reference in its entirety.

    	 	 3	 

     

    

13.            
COUNTERSIGNATURE. This Forbearance Agreement shall become effective only when it shall have been executed by Borrower
and Bank.

[Signature page
follows.]

 

    	 	 4	 

     

    

This Forbearance Agreement
is executed as of the date first written above.

 

	BANK:	 	 	 	 
	 	 	 	 	 	 
	SILICON VALLEY BANK	 	 	 	 
	 	 	 	 	 	 
	 	 	 	 	 	 
	By	/s/ Zach Norris	 	 	 	 
	Name:  	Zach Norris

	 	 	 	 
	Title:	Vice President

	 	 	 	 
	 	 	 	 	 	 
	 	 	 	 	 	 
	 	 	 	 	 	 
	BORROWER:	 	 	 	 
	 	 	 	 	 	 
	 	 	 	 	 	 
	XTANT MEDICAL HOLDINGS, INC.	 	BACTERIN INTERNATIONAL, INC.	 
	 	 	 	 	 	 
	By	/s/ John P. Gandolfo	 	By	/s/ John P. Gandolfo	 
	Name:  	John P. Gandolfo	 	Name:  	John P. Gandolfo	 
	Title:	CFO	 	Title:	CFO	 
	 	 	 	 	 	 
	 	 	 	 	 	 
	X-SPINE SYSTEMS, INC.	 	XTANT MEDICAL, INC.	 
	 	 	 	 	 	 
	By	/s/ John P. Gandolfo	 	By	/s/ John P. Gandolfo	 
	Name:  	John P. Gandolfo	 	Name:  	John P. Gandolfo	 
	Title:	CFO	 	Title:	CFO	 
	 	 	 	 	 	 

 

 

    	 	 5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00270-of-00352.parquet"}]]